HOSTED PROTOTYPE

Use synthetic data only. No prescriptions are issued or medications dispensed.

PoeRx
HomeCompareWegovy vs. Zepbound
Weight management & diabetes

Compare Wegovy vs. Zepbound

Compare two prescription options commonly discussed for chronic weight management: semaglutide and tirzepatide.

MEDICAL REVIEW REQUIREDFDA and DailyMed labeling · editorial prototype

Key takeaways

  • Wegovy contains semaglutide; Zepbound contains tirzepatide.
  • They work through related but different incretin pathways and are not interchangeable products.
  • The appropriate choice depends on approved indications, medical history, current medicines, risks, access, and personal treatment goals.

How they compare

EDITORIAL GUIDE
TopicWegovysemaglutideZepboundtirzepatide
Active ingredientSemaglutideTirzepatide
Medication classGLP-1 receptor agonistGIP/GLP-1 receptor agonist
Common FDA-approved focusChronic weight management for eligible patientsChronic weight management for eligible patients
AccessPrescription requiredPrescription required
DecisionRequires an individual clinician reviewRequires an individual clinician review

Primary sources

Labeling can change. Use the current FDA prescribing information and speak with a licensed clinician or pharmacist before making a treatment decision.

Wegovy FDA label Zepbound FDA label